Stem cell startup claims IP from local hospitals
Intellectual property surrounding stem cell modulators, and belonging both to Children’s Hospital Boston and Massachusetts General Hospital, has been granted exclusively to Fate Therapeutics Inc., a La Jolla, Calif.-based biotech that houses some of its research in the Boston area.
[Read the full article here]Related News:
Fate Therapeutics Granted Exclusive License for Stem Cell Modulators …
Fate Therapeutics, Fast-Growing Stem Cell Shop, Looks to Add Big …
Fate Therapeutics Growing Fast on “Industrialized” Stem Cell …